Podcast · Santé & Pharma
The Road to Care
SamaCare leads healthcare innovation by uniting providers, administrators, and policymakers to eliminate barriers in patient access to specialty care.
⏱ 8 min read · Readable by ChatGPT, Gemini, Claude
The Road to Care brings together healthcare providers, administrators, pharmaceutical manufacturers, investors, and policymakers to address the systemic barriers blocking patient access to critical specialty treatments. Episodes explore administrative hurdles, clinical innovations, emerging health technologies, and policy solutions that reshape how patients reach the care they need. The podcast examines real-world business development practices, bioelectronic medicine, blockchain patient data solutions, and remote therapeutic monitoring—practical insights for professionals navigating healthcare's transformation.
- The podcast is sponsored by SamaCare, a healthcare technology company focused on eliminating administrative barriers to patient care access.
- Episodes unite five stakeholder groups: healthcare providers, administrators, pharmaceutical manufacturers, investors, and policymakers—creating cross-sector dialogue rarely found in mainstream healthcare content.
- Recent episodes reveal deep expertise in bioelectronic medicine, blockchain-based patient data protection, AI-driven medical innovation, and remote therapeutic monitoring—emerging technologies reshaping specialty care delivery.
- The podcast prioritizes actionable business development insights and clinical trends over generalist healthcare commentary, targeting professionals making strategic decisions in hospital systems, pharma companies, and health tech startups.
Explore all episodes of The Road to Care to discover how industry leaders are addressing healthcare access challenges.
What this podcast really covers
The Road to Care is not a general healthcare podcast. It targets the operational and strategic challenges blocking patient access to specialty treatments—prior authorizations, formulary restrictions, insurance denials, supply chain inefficiencies. Episodes systematically examine how administrative complexity slows care delivery and what institutional changes accelerate it.
Beyond administrative optimization, the podcast explores emerging technologies as direct solutions to access barriers: blockchain for patient data security, AI signal processing for diagnostic accuracy, remote monitoring for continuous care, bioelectronic medicine for chronic disease management. Each technology episode roots innovation in patient outcomes, not hype.
The podcast also addresses pharmaceutical development timelines, research democratization, and policy influence. Episodes with ex-Novartis executives and DC policymakers establish that pharmaceutical access involves regulatory strategy, not just clinical efficacy. This positions The Road to Care as essential intelligence for C-level pharmaceutical leaders and policy-facing healthcare administrators—an uncommon focus in B2B health podcasts.
Who this podcast is essential for
Healthcare System Executives and Hospital Administrators gain direct intelligence on reducing administrative friction—prior authorization automation, infusion care optimization, supply chain transparency. Episodes on business development practices and real-world provider strategies offer replicable frameworks for improving patient access metrics and operational efficiency.
Pharmaceutical and Health Tech Leaders discover emerging market opportunities and regulatory pathways. Episodes featuring startup founders, blockchain innovators, and AI researchers reveal where pharmaceutical value creation intersects with patient access barriers—helping manufacturers and tech companies align innovation with market demand.
Healthcare Investors and Policy Professionals extract strategic intelligence on which healthcare access innovations have durable competitive moats and policy support. Episodes with Hall of Famers, ex-Novartis executives, and DC advocates indicate that The Road to Care attracts established voices shaping healthcare's future, not peripheral players.
What the episodes really reveal
Episode titles point to a podcast methodology: identify specific patient access barriers, then bring domain experts who have solved them. "Optimizing Infusion Care: Lessons from WeInfuse" isolates a care modality and extracts operational wins. "How to Succeed As a Health Tech Startup" distills success patterns. "Democratizing Pharmaceutical Research" challenges the assumption that drug development remains locked behind pharma gates.
The presence of a Hall of Famer (Jeremy Roenick, blockchaining patient data protection), an ex-Novartis C-suite member (Scott Howell on pharmaceutical research), and Washington advocates ("No Holds Barred on Repairing a Broken System") signals that The Road to Care attracts both operational experts and strategic voices. This is not influencer marketing—it is subject-matter authority assembled across hospital systems, biotech, policy, and digital health.
Recurring themes—administrative simplification, data interoperability, remote monitoring, chronic disease prevention, policy alignment—form a coherent thesis: patient access improves when institutions digitize workflows, share data securely, and coordinate across silos. This thesis is tested through dozens of episodes, giving listeners a repeatable mental model for healthcare transformation.
What this changes in practice
Healthcare professionals listening to The Road to Care gain a strategic playbook: identify where your institution slows patient access (authorization delays, formulary denials, supply gaps), find which technology or operational change others have used to solve it, and test that change internally. Episodes on infusion care, remote monitoring, and blockchain patient records provide specific, replicable solutions—not generic advice.
The podcast also shifts perspective on pharmaceutical innovation: access barriers are not inevitable. Episodes featuring pharmaceutical leaders and health tech founders demonstrate that companies profiting from complexity have no incentive to eliminate it—but that regulation, technology, and competition are reducing those incentives. This actionable reframing helps healthcare professionals distinguish between genuine clinical constraints and institutional inertia.
For investors and policymakers, The Road to Care establishes that healthcare access is an investment thesis, not a charity narrative. Bioelectronic medicine reduces hospitalizations; blockchain reduces data breaches; AI accelerates diagnosis. These are profitable innovations that also improve patient outcomes. The podcast's emphasis on business development and unit economics ensures that healthcare access solutions are built to scale, not destined for pilot-program purgatory.
Listen to The Road to Care on Listenly and apply these healthcare access strategies to your institution.
Start listening to episodes on healthcare access innovation to hear from providers, pharmaceutical leaders, and policymakers reshaping patient care delivery.
The podcast answers these questions
What administrative barriers prevent patient access to specialty treatments?
Administrative complexity in prior authorizations, formulary restrictions, and insurance coverage denials creates significant delays in patient care pathways. Healthcare providers spend substantial resources navigating these barriers, delaying critical treatment initiation for patients who need timely interventions. Streamlining approval processes and reducing bureaucratic friction directly improves patient outcomes.
How are health tech startups disrupting pharmaceutical access?
Emerging health tech platforms leverage blockchain, AI, and connected care solutions to digitize patient data, automate approval workflows, and enhance supply chain transparency. These innovations reduce manual processes, accelerate treatment initiation, and enable real-time monitoring of patient outcomes across distributed healthcare networks. Success requires balancing regulatory compliance with rapid deployment.
What role does data interoperability play in modern healthcare delivery?
Data interoperability enables seamless information flow between providers, insurers, and patients, eliminating data silos that fragment care delivery. Standardized data formats and secure patient records reduce duplicate testing, streamline clinical decision-making, and enable real-time therapeutic monitoring. Connected care ecosystems depend on robust data governance and privacy protections.
How can pharmaceutical innovation reach underserved patient populations?
Democratizing research access, reducing development timelines, and leveraging real-world evidence enables pharmaceutical companies to address unmet needs in underrepresented populations. Collaborating with policymakers and community health networks identifies market gaps where innovation creates both clinical and commercial value. Patient-centric research design ensures treatments reach those who need them most.